Bill > S3105

This bill, known as the Increase Support for Life-saving Endocrine Transplantation (ISLET) Act, aims to regulate human cadaveric islets (specialized cells in the pancreas that produce insulin) as organs for transplantation. The bill amends the Public Health Service Act to explicitly include human cadaveric islets in the definition of transplantable organs. It also clarifies that human cadaveric islets are not considered drugs, biological products, or human cells, tissues, or cellular products under existing regulations. The bill requires the Secretary of Health and Human Services to update relevant regulations within one year of enactment to accommodate this change and to provide a report to Congress within six months detailing the progress of these regulatory updates. By creating a specific regulatory pathway for islet transplants, the bill seeks to potentially improve access to and standardization of this medical procedure, which could be particularly beneficial for patients with certain types of diabetes who might benefit from islet cell transplantation.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/3105/all-info